- Dorsey, Morna;
- Dorsey, MJ;
- Dorsey, MJ;
- Ho, V;
- Mabudian, M;
- Soler-Palacín, P;
- Domínguez-Pinilla, N;
- Rishi, R;
- Rishi, R;
- Wong, D;
- Rojavin, M
Purpose This retrospective study evaluated the effectiveness and tolerability in clinical practice of an L-proline-stabilized 10 % intravenous immunoglobulin (IVIG; Privigen®) in patients with primary (PID) or secondary immunodeficiency (SID). Methods Pati